Experts believe they won't get the upper hand on the disease until they persuade enough people that a healthy diet and regular exercise can prevent it or minimize its damage if it has already struck.
How well is the media doing its job to vet sources' ties to pharmaceutical funding? New research shows that academics who promoted the use of antiviral drugs for swine flu were eight times more likely to have financial links to drug companies.
Marketed to men, testosterone is supposed to be a way to stay young and virile. Marketed to women, it is supposed to be a way to recapture waning sexual desire and boost the libido.
Innovative health reforms in Oregon, new recommendations on hormones for women, an intensive treatement for hypertension, the spread of Chagas disease and more from our Daily Briefing.
There was a time when menopausal hormone therapy was seen as a near-panacea for the ills of the aging woman. That was before Marcia Stefanick and her Women’s Health Initiative (WHI) colleagues put the theory to the test and upended the medical world.
A moving examination of how doctors choose to die, a big-money Prempro lawsuit, and FDA scrutiny of the HCG diet, plus more from our Daily Briefing.
On World Neuroendocrine Tumor Awareness Day, Mitchell Berger shares his own experience with this rare type of cancer and examines what the media got wrong in reporting on Steve Jobs' death.
Rising rates of unvaccinated kids, bird flu/H5N1 reemerges, and a looming doctor shortage, plus more in today's Daily Briefing
Millions of American women were put on hormone replacement therapy before science evaluated the benefits and harms. Will men over 45 try testosterone replacement therapy too? Aggressive marketing of testosterone is on the rise.
A landmark court case over Medicaid cuts, soy slammed for menopause, and bureaucratic delays in HIV/AIDS care for some Atlantans, plus more from our Daily Briefing.
